HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case-Control Studies.

Abstract
Rationale: Millions of workers around the world are exposed to respirable crystalline silica. Although silica is a confirmed human lung carcinogen, little is known regarding the cancer risks associated with low levels of exposure and risks by cancer subtype. However, little is known regarding the disease risks associated with low levels of exposure and risks by cancer subtype.Objectives: We aimed to address current knowledge gaps in lung cancer risks associated with low levels of occupational silica exposure and the joint effects of smoking and silica exposure on lung cancer risks.Methods: Subjects from 14 case-control studies from Europe and Canada with detailed smoking and occupational histories were pooled. A quantitative job-exposure matrix was used to estimate silica exposure by occupation, time period, and geographical region. Logistic regression models were used to estimate exposure-disease associations and the joint effects of silica exposure and smoking on risk of lung cancer. Stratified analyses by smoking history and cancer subtypes were also performed.Measurements and Main Results: Our study included 16,901 cases and 20,965 control subjects. Lung cancer odds ratios ranged from 1.15 (95% confidence interval, 1.04-1.27) to 1.45 (95% confidence interval, 1.31-1.60) for groups with the lowest and highest cumulative exposure, respectively. Increasing cumulative silica exposure was associated (P trend < 0.01) with increasing lung cancer risks in nonsilicotics and in current, former, and never-smokers. Increasing exposure was also associated (P trend ≤ 0.01) with increasing risks of lung adenocarcinoma, squamous cell carcinoma, and small cell carcinoma. Supermultiplicative interaction of silica exposure and smoking was observed on overall lung cancer risks; superadditive effects were observed in risks of lung cancer and all three included subtypes.Conclusions: Silica exposure is associated with lung cancer at low exposure levels. An exposure-response relationship was robust and present regardless of smoking, silicosis status, and cancer subtype.
AuthorsCalvin Ge, Susan Peters, Ann Olsson, Lützen Portengen, Joachim Schüz, Josué Almansa, Thomas Behrens, Beate Pesch, Benjamin Kendzia, Wolfgang Ahrens, Vladimir Bencko, Simone Benhamou, Paolo Boffetta, Bas Bueno-de-Mesquita, Neil Caporaso, Dario Consonni, Paul Demers, Eleonóra Fabiánová, Guillermo Fernández-Tardón, John Field, Francesco Forastiere, Lenka Foretova, Pascal Guénel, Per Gustavsson, Vikki Ho, Vladimir Janout, Karl-Heinz Jöckel, Stefan Karrasch, Maria Teresa Landi, Jolanta Lissowska, Danièle Luce, Dana Mates, John McLaughlin, Franco Merletti, Dario Mirabelli, Nils Plato, Hermann Pohlabeln, Lorenzo Richiardi, Peter Rudnai, Jack Siemiatycki, Beata Świątkowska, Adonina Tardón, Heinz-Erich Wichmann, David Zaridze, Thomas Brüning, Kurt Straif, Hans Kromhout, Roel Vermeulen
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 202 Issue 3 Pg. 412-421 (08 01 2020) ISSN: 1535-4970 [Electronic] United States
PMID32330394 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Silicon Dioxide
Topics
  • Adenocarcinoma of Lung (epidemiology)
  • Adult
  • Aged
  • Canada (epidemiology)
  • Carcinoma, Small Cell (epidemiology)
  • Carcinoma, Squamous Cell (epidemiology)
  • Cigarette Smoking
  • Europe (epidemiology)
  • Female
  • Humans
  • Inhalation Exposure
  • Lung Neoplasms (epidemiology, pathology)
  • Male
  • Middle Aged
  • Occupational Exposure (statistics & numerical data)
  • Silicon Dioxide
  • Silicosis (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: